Table 1.
Details of patients presenting with candida esophagitis and controls
| Cases | Control | |
| n = 51 | n = 102 | |
| Sex | ||
| Male | 27 (53) | 58 (57) |
| Female | 24 (47) | 44 (43) |
| Age in years (yrs) | ||
| Range: | 21-77 | 19-74 |
| Mean ± SD | 52.9 ± 14.6 | 50.08 ± 12.64 |
| No: % of In-patients | 34 (64) | 58 (54) |
| Risk factors for candida esophagitis | ||
| Steroid therapy | 15 (29.4%) | 6 (5.8%) |
| Diabetes mellitus type 1 and 2 | 14 (27.4%) | 5 (4.9%) |
| Carcinoma | 10 (19.6%) | 3 (2.9%) |
| (e.g. breast, gastric, esophagus) | ||
| Broad spectrum antibiotics | 8 (15.6%) | 4 (3.9%) |
| Chronic liver disease | 2 (3.9%) | 6 (5.8%) |
| Tuberculosis | 2 (3.9%) | 1 (0.9%) |
| Ischemic heart disease | - | 26 (25.4%) |
| Peptic ulcer disease | - | 26 (25.4%) |
| Hypertension | - | 20 (19.6%) |
| Chronic anemia | - | 2 (1.9%) |
| Arthritis | - | 1 (0.9%) |
| Primary Infertility | - | 1 (0.9%) |
| Osteoporosis | - | 1 (0.9%) |
| Clinical symptoms | ||
| Retrosternal discomfort | 20 (39.3%) | 31 (30.3%) |
| Dysphagia | 13 (25.4%) | 20 (19.7%) |
| Epigastric symptoms | 18 (35.3%) | 51 (50%) |
| Endoscopic grading | ||
| Grade 1 | 9 | |
| Grade 2 | 19 | |
| Grade 3 | 10 | |
| Grade 4 | 13 | |
| Treatment | ||
| Nystatin | 84.3% (43/51) | |
| Fluconazole | 15.7% (8/51) |
Results were expressed as number and percentage, mean ± standard deviation (SD).